NMRAL1

Chr 16

NmrA like redox sensor 1

Also known as: HSCARG, SDR48A1

This gene encodes a redox sensor protein that binds NADPH and regulates cellular responses to changes in NADPH/NADP+ ratios, including modulation of nitric oxide synthesis and interferon signaling pathways. The gene is not highly constrained against loss-of-function variants based on population data (pLI < 0.9, LOEUF > 0.35), suggesting that complete loss of function may be tolerated. No established Mendelian diseases have been definitively associated with NMRAL1 mutations in current medical literature.

ResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.33
Clinical SummaryNMRAL1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
30 unique Pathogenic / Likely Pathogenic· 75 VUS of 120 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.33LOEUF
pLI 0.000
Z-score 0.76
OE 0.76 (0.461.33)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.73Z-score
OE missense 1.15 (1.031.29)
216 obs / 187.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.76 (0.461.33)
00.351.4
Missense OE1.15 (1.031.29)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 9 / 11.8Missense obs/exp: 216 / 187.7Syn Z: -0.83
DN
0.7131th %ile
GOF
0.6540th %ile
LOF
0.2581th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

120 submitted variants in ClinVar

Classification Summary

Pathogenic30
VUS75
Likely Benign3
30
Pathogenic
75
VUS
3
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
0
0
0
VUS
0
65
10
0
75
Likely Benign
0
3
0
0
3
Benign
0
0
0
0
0
Total068400108

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NMRAL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗